This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Lancefieldella parvula: NCBI 1382, [species]

Back to details

| "Streptococcus parvulus" Weinberg et al. 1937| ATCC 33793| Atopobium parvulum| Atopobium parvulum (Weinberg et al. 1937) Collins and Wallbanks 1993| CCUG 32760| CIP 102970| DSM 20469| JCM 10300| Peptostreptococcus parvulus| Peptostreptococcus parvulus (Weinberg et al. 1937) Smith 1957 (Approved Lists 1980)| strain IPP 1246| Streptococcus parvulus| Streptococcus parvulus (Weinberg et al. 1937) Cato 1983| VPI 0546

  1. Environmental Role: Flavobacterium aquatile and other members of the genus Flavobacterium are known for their diverse metabolic capabilities and their ability to degrade complex organic compounds in aquatic environments. They contribute to nutrient cycling, organic matter decomposition, and the maintenance of ecosystem balance in freshwater and marine habitats.

  2. Biotechnological Applications: Some Flavobacterium species, including Flavobacterium aquatile, have been studied for their potential biotechnological applications, particularly in the fields of wastewater treatment, bioremediation, and aquaculture. They may have roles in the degradation of pollutants and the production of enzymes or bioactive compounds with industrial or environmental significance.

  3. Rare Human Infections: While Flavobacterium aquatile is not considered a common human pathogen, there have been rare reports of infections in humans, typically associated with immunocompromised individuals or those with underlying medical conditions. In such cases, Flavobacterium aquatile infections may present as opportunistic infections, such as wound infections, bacteremia, or urinary tract infections.

  4. Prevention: Preventive measures to minimize the risk of infections with Flavobacterium aquatile or other environmental bacteria include maintaining good hygiene practices, avoiding exposure to contaminated water sources, and implementing proper wound care and infection control measures, particularly in healthcare settings.

Other Sources for more information:

Legend

Lancefieldella parvula impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.388724774122238160.6998615860939026Mogibacterium diversumParent Taxa
0.36781892180442810.6964573264122009Schaalia odontolyticaParent Taxa
0.32844635844230650.6523483991622925Actinomyces pacaensisParent Taxa
0.323258310556411740.6520902514457703Rothia dentocariosaParent Taxa
0.312984049320220950.5246357917785645Pseudomonas protegensParent Taxa
0.295977473258972170.6082083582878113Actinomyces orisParent Taxa
0.28877964615821840.7044016122817993Rothia amaraeParent Taxa
0.26524332165718080.5931100249290466Streptococcus parasanguinisParent Taxa
0.254427075386047360.580021858215332Limosilactobacillus panisParent Taxa

Other bacteria of the same rank impacting Lancefieldella parvula

R2SlopeTax NameParent Chart
0.296801000833511350.6216092109680176Rothia dentocariosaParent Taxa
0.293780714273452760.5200698375701904Streptococcus parasanguinisParent Taxa
0.274906635284423830.5266456604003906Streptococcus sp. HSISM1Parent Taxa
0.267634898424148560.48780784010887146Schaalia odontolyticaParent Taxa
0.25492224097251890.5053868889808655Streptococcus sp. LPB0220Parent Taxa
0.251629650592803960.5673986077308655Schaalia meyeriParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]